Applying Bioinformatic Tools for Modeling and Modifying Type II E. coli l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia.

Background: Asparginase is known to be one of the most important bedrocks of acute lymphoblastic leukemia (ALL) treatment in almost all pediatric regimens in treatment protocols. Escherichia coli L-Asparginase (EC 3.5.1.1) is one of the most common resources to produce this enzyme. One of the afford...

Full description

Bibliographic Details

Published in:	International Journal of Cancer Management Vol. 10; no. 3; pp. 1 - 11
Main Authors:	Mahboobi, Mahdieh, Sedighian, Hamid, Hedayati C. H., Mojtaba, Bambai, Bijan, Soofian, Saeed Esmaeil, Amani, Jafar
Format:	pictorial research tables/charts Journal Article
Published:	Medical Journals Commission of the Ministry of Health & Medical Education Mar2017
Online Access:	View this record in EBSCOhost